Literature DB >> 7917526

The molecular basis of cisplatin sensitivity/resistance.

L R Kelland1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7917526     DOI： 10.1016/0959-8049(94)90281-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  8 in total

1.  The trans labilization of cis-[PtCl2(13CH3NH2)2] by glutathione can be monitored at physiological pH by [1H,13C] HSQC NMR.

Authors:  Dan Gibson; Yonit Kasherman; Dina Kowarski; Inna Freikman
Journal:  J Biol Inorg Chem       Date:  2005-12-10       Impact factor: 3.358

2.  Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin.

Authors:  A M Otto; R Paddenberg; S Schubert; H G Mannherz
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts.

Authors:  Yonit Kasherman; Stefan Sturup; Dan Gibson
Journal:  J Biol Inorg Chem       Date:  2008-12-04       Impact factor: 3.358

4.  Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.

Authors:  H Parekh; H Simpkins
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

5.  Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.

Authors:  Bernd Liedert; Dick Pluim; Jan Schellens; Jürgen Thomale
Journal:  Nucleic Acids Res       Date:  2006-03-29       Impact factor: 16.971

6.  A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.

Authors:  G Pratesi; P Perego; D Polizzi; S C Righetti; R Supino; C Caserini; C Manzotti; F C Giuliani; G Pezzoni; S Tognella; S Spinelli; N Farrell; F Zunino
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

7.  DFT Study on the Substituent Effect of Anticancer Picoline-Diazido-Pt(IV) Compounds.

Authors:  Meilin Mu; Hongwei Gao
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

8.  Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.

Authors:  M W Sark; H Timmer-Bosscha; C Meijer; D R Uges; W J Sluiter; W H Peters; N H Mulder; E G de Vries
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.